IHH supportive of efforts to rein in medical inflation


KUALA LUMPUR: IHH Healthcare Bhd said it is supportive of the government's efforts to rein in medical inflation. 

However, it believes that it is crucial to enact policies that holistically address the issue by considering the healthcare financing structure and its various stakeholders, and not focus strictly on drug price controls per se. 
 
IHH also said it remains fully aligned with Association of Private Hospitals Malaysia’s call and efforts to continue collaborative engagement with the authorities and broader stakeholders to ensure an effective solution to tackle medical inflation in Malaysia.

Its managing director and CEO Dr Tan See Leng also said after it’a AGM he was unable to reveal the profit margins of its hospital’s drug division or IHH’s pharmaceutical division because certain more complex procedures using the same drugs required more technical expertise to administer.

IHH is the owner and operator of the Pantai and Gleneagles private hospitals in Malaysia.

Tan, 54, will be leaving the group once his contract expires on Dec 31, 2019.

Meanwhile, Dr Kelvin Loh Chi-Keon, 45, who is currently the Columbia Asia Group CEO, will take over the helm of IHH starting next year.

(An earlier version of this story titled “IHH supportive of drug price control mechanism” is now updated / corrected to this version)


Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

IHH Healthcare

   

Next In Business News

Tenaga plans US$1bil IPO for power business, sources say
Construction industry players appeal government to review industry regulations
Ringgit ends higher against US dollar for fourth consecutive day
Tan Chong gets 4-year extension for its solar project PPA
Heineken Malaysia reports three-fold increase in 2Q net profit
Tengku Zafrul: Google Cloud will enable Malaysia to move forward digitally
Bursa Malaysia advances on better-than-expected GDP
Core inflation forecast at upper range of 2% to 3% in 2022
Indonesia rupiah hits two-month high among mixed Asian FX
Asian stocks fall on nagging Fed rate hike worries

Others Also Read